Pulmonary alterations in cocaine users

Alterações pulmonares em usuários de cocaína

REVIEW ARTICLE

Pulmonary alterations in cocaine users

Alterações pulmonares em usuários de cocaína

Mário Terra Filho; Chen Chin Yen (deceased); Ubiratan de Paula Santos; Daniel Romero Muñoz

Division of Pulmonary Diseases, Instituto do Coração and Laboratório de Investigação Médica (LIM-40), Department of Legal Medicine, Faculdade de Medicina, Universidade de São Paulo, Brasil

^{Correspondence}

ABSTRACT

CONTEXT: Brazilian researchers have recently recognized a marked increase in the number of people using abusable drugs and the consequences of this habit. It has become a major public health problem in a potentially productive segment of the general population. In the last few years, several medical articles have given special emphasis to pulmonary complications related to cocaine use. This review is based on this information and experience acquired with groups of cocaine users.

OBJECTIVE: To present to physicians the pulmonary aspects of cocaine use and warn about the various effects this drug has on the respiratory system, stressing those related to long-term use.

DESIGN: Narrative review.

METHOD: Pulmonary complications are described. These may include infections (Staphylococcus aureus, pulmonary tuberculosis, acquired immunodeficiency syndrome/aids, etc.), aspiration pneumonia, lung abscess, empyema, septic embolism, non-cardiogenic pulmonary edema, barotrauma, pulmonary granulomatosis, bronchiolitis obliterans and organizing pneumonia, pneumonitis and interstitial fibrosis, pneumonitis hypersensitivity, lung infiltrates and eosinophilia in individuals with bronchial hyperreactivity, diffuse alveolar hemorrhage, vasculitis, pulmonary infarction, pulmonary hypertension and alterations in gas exchange. It is concluded that physicians should give special attention to the various pulmonary and clinical manifestations related to cocaine use, particularly in young patients.

Key words: Crack cocaine. Drug abuse. Dependency. Cocaine. Lung.

RESUMO

CONTEXTO: Recentemente, os pesquisadores brasileiros reconheceram que o número de pessoas que utilizam drogas de abuso e as conseqüências decorrentes desse hábito aumentaram consideravelmente, constituindo, hoje, um dos maiores problemas de saúde pública abrangendo uma camada de população potencialmente produtiva. Nos últimos anos, vários artigos médicos têm dado especial ênfase às complicações pulmonares relacionados ao uso de cocaína nos seus usuários. Com base nessas informações e na experiência adquirida com grupos de usuários de cocaína, redigimos esta revisão com o intuito de alertar a classe médica quanto aos diferentes efeitos no sistema respiratório.

OBJETIVO: Apresentar aos médicos os aspectos pulmonares envolvidos com o uso da cocaína e alertá-los quanto aos diversos efeitos dessa droga sobre o aparelho respiratório, ressaltando aqueles relacionados com o uso a longo prazo.

TIPO DE ESTUDO: Revisão narrativa.

MÉTODO: São descritas complicações pulmonares, tais como, infecções (Staphylococcus aureus, tuberculose pulmonar e extrapulmonar, síndrome da imunodeficiência adquirida, aids, etc.), pneumonia aspirativa, abscesso pulmonar, empiema, embolia séptica, edema pulmonar não-cardiogênico, barotrauma, granulomatose pulmonar, bronquiolite obliterante com pneumonia em organização, pneumonite e fibrose intersticial, pneumonite por hipersensibilidade, infiltrados pulmonares e eosinofilia em pessoas com hiper-reatividade brônquica, hemorragia alveolar difusa, vasculite, enfarto pulmonar, hipertensão pulmonar e alterações de troca gasosa. Assim, é necessário que os médicos atentem, hoje em dia, na sua rotina diária, para as diversas complicações pulmonares e manifestações clínicas associados ao uso de cocaína, particularmente nos jovens.

Palavras-chave: Cocaína crack. Cocaína. Drogas de abuso. Abuso de cocaína. Transtornos relacionados ao uso de cocaína. Dependência de cocaína.

INTRODUCTION

An illicit drug can be defined as any substance that is forbidden or not authorized by law and society's rules. Drug abuse refers to the consumption of licit or illicit drugs in order to attain an altered mental state.¹ Thus, a drug is considered to be an abusable drug when it can be used for non-medical purposes and leads to addiction (compulsive use, loss of control over consumption and continued use in spite of social, economic or medical consequences). According to the World Health Organization (WHO), drug dependence corresponds to "the mental state, and often a physical state, resulting from the interaction between a living organism and a drug". It is characterized by behavior that always includes the compulsion to take the drug in order to experience its psychic effect and sometimes to avoid the discomfort of its absence.²

Drug abuse has reached considerable proportions in the last few years,³ and currently ranks as a major public health problem. The use of illegal drugs has spread to potentially productive segments of the general population, predominantly young⁴ adult men.^5-7 In Brazil, surveys carried out by Cebrid (Brazilian Information Center on Psychotropic Drugs),^8,9 Grea (Interdisciplinary Study Group on Alcohol and Drugs)¹⁰ and Denarc (State Department of Narcotics Investigations)¹¹ have shown increasing consumption of such drugs, particularly of cocaine. In other studies involving Brazilian students,^12,13 it was shown that 90% of the participants had already tried some illegal drug at least once, such drugs were predominantly used by men and consumption of abusable drugs had begun at an early age, around 10-12 years old.¹⁴ Among the abusable drugs, alcohol, marijuana and cocaine are the ones most consumed worldwide, in the salt or base forms.^14,15 Most users take them simultaneously or report previous use of other drugs. In general, cocaine is used with alcohol.^7,16-19 Interaction between alcohol and cocaine results in the formation of cocaethylene,²⁰ which can increase the effects and toxicity of cocaine.¹⁶ Some authors have reported that ethanol and cocaine association increases the risk of sudden death.^{21, 22}

Muñoz et al.²³ studied the use of alcohol, marijuana and cocaine in 63 victims of violent death in the city of Guarulhos (state of São Paulo, Brazil). Blood and urine samples obtained during autopsy were used in the study, and 61.9% of the victims were positive for the three drugs. Alcohol was detected in 53.33%, cocaine or its metabolites were found in 25.86% and cannabinoids in 17.24% of the cases. In an analysis of hair samples from 38 victims of the same group with positive results for cocaine in urine, Toledo et al.²⁴ found this drug or its metabolite (benzoylecgonine) in all samples.

Cocaine is an alkaloid found in the leaves of Erythroxylon coca, commonly known as coca, a native plant of the Andean and Amazon regions in South America. It was first extracted and identified by the German chemist Albert Niemann in the mid-19th century.²⁵ The inhabitants of the Andes chewed the leaves to ward off fatigue, hunger and thirst, to enhance endurance, and to promote a sense of wellbeing. Because of its pharmacological properties, it had medical use as a tonic/elixir for several diseases and also as local anesthetic in eye, ear and throat surgery.¹ It was subsequently replaced by synthetic anesthetics such as lidocaine.²⁶ Cocaine was also used in popular beverages and the most popular of these were Vin Mariani and Coca-Cola in its original formulation.¹ It has no therapeutic indication today and its importance derives from being considered to be an abusable drug.

Cocaine is a powerful central nervous system stimulant and has very complex activity, both through central and peripheral pathways. Its anesthetic effect is achieved by blocking sodium influx in the nerve cell membrane, thereby preventing nervous transmission.^25,27,28 It is assumed that alterations in dopamine transport are the mechanism for the euphoric and compulsive effects of cocaine.^29-33

This illicit drug is sold on the street, mixed with similar-looking substances like lidocaine, talcum powder or sugar. Cocaine is generally consumed in freebase form or smoked as "crack". It can be absorbed via intranasal, intravenous or vaginal routes in the hydrochloride form or by massaging the gums in coca paste form (prepared using solvents like kerosene and gasoline). It can be smoked either in pipes or cigarettes.¹

"Crack"^34,35 was developed in the second half of the 1980s, when the characteristics of cocaine were altered so that it could be smoked. Crack is prepared by heating and evaporating the hydrochloride with a base (generally sodium bicarbonate). After cooling, irregular crystals or "rocks" are the final result. These produce a cracking sound when heated.^33,36 Thus, it became known as "crack"⁵ and has become the most popular form for consumption of this drug. Cocaine obtained by this process may be 100% pure, but the purity can be as low as 20% because contaminants are not always removed and the drug is often further adulterated by the producer.⁶

Pulmonary effects of cocaine

There are several organic consequences (Table 1) resulting from the chronic use of cocaine by different administration routes and its local or systemic pharmacological effects. Among these are adverse effects on the lungs.³⁷ Respiratory system alterations depend not only on the administration route, but also on the dose and time of use, presence of microbiological contaminants or substances used to adulterate the sample, sharing of paraphernalia used for the drug consumption and host responses of the individual user.³⁸ Small doses of cocaine cause acute respiratory stimulation and large doses lead to respiratory depression. In some users, however, cocaine can promote an undesirable paradoxical effect with an initial increase in respiratory rate and depth followed by depression.²

When crack is smoked, the lungs are directly exposed to the volatile drug and to the products resulting from its combustion. Rapidly absorbed by the mucous membrane and alveolar epithelium, the drug reaches the bloodstream almost immediately, providing the user with a more rapid and intensive physiological and psychological effect than is obtained by intravenous injection.^32,39

Smoking cocaine can produce acute lung injury, and several hypotheses have been proposed to explain this. These include cell anoxia resulting from the cocaine-induced lung vasoconstriction; direct toxic effect on the alveolar capillary endothelium and bronchial epithelium; and hypersensitivity reaction to basic cocaine components.^33,36,40

Several pulmonary complications related to cocaine use (Table 2) and administration route have been reported in the literature. Opportunistic and secondary systemic infections with pulmonary involvement have been reported (Staphylococcus aureus, pulmonary tuberculosis or aids^33,41 due to poor cleaning of the paraphernalia used),³³ aspiration pneumonia and lung abscess, empyema and pulmonary granulomatosis.^6,42-44 Thrombophlebitis and septic endocarditis with release of emboli, septic emboli, pulmonary artery obstruction, mycotic aneurysms (pulmonary artery) and lung infiltrates have been described in relation to intravenous cocaine use.³⁸

Barotrauma and bullous emphysema

Pneumothorax and pneumomediastinum^1,38,45-48 are commonly related to cocaine inhalation or smoking, in the freebase or crack forms. These complications result from coughing or intense Valsalva's maneuver performed to heighten the effect of the drug, thereby leading to a sudden increase in intrabronchial and intra-alveolar pressure with subsequent alveolar rupture and air penetration in the pulmonary interstitium.⁴¹ The free air can dissect the peribronchial connective tissue in the mediastinum, pericardium, pleural cavity and subcutaneous tissues, resulting in pneumopericardium⁴⁸ and subcutaneous emphysema.⁴⁹ Gurney and Bates⁵⁰ reported the occurrence of bullous emphysema in 10 drug users: they were all young, smokers (3 of them for less than 3 years), with normal alpha-1 antitrypsin serum levels.

Pulmonary edema and immune-mediated pulmonary disease

Reports in the literature describe noncardiogenic pulmonary edema in cocaine users, especially after crack smoking^38,51-53 Although the precise mechanism is unclear, some authors believe that there is a relationship with increased lung capillary permeability, since bronchoalveolar lavage fluid from cocaine users has shown increased protein concentration.⁵¹

There are reports^53-55 in the literature suggesting that crack users can develop pulmonary hypersensitivity reaction with bronchospasm exacerbation.

Alveolar hemorrhage

Alveolar hemorrhage has been described in the last ten years as one of the pulmonary complications caused by cocaine use.^38,41,56-58 In 1988, Murray et al.⁵⁹ reported the first case of alveolar hemorrhage and hypoxemic respiratory failure associated with freebase cocaine smoking, and open-chest biopsy revealed diffuse alveolar hemorrhage. The two cases published by Bouchi et al.⁶⁰ had hemoptysis and dyspnea symptoms, and alveolar hemorrhage was seen via bronchoscopy as blood originating from the bronchial openings, and via bronchoalveolar lavage as hemosiderin in alveolar macrophages. This last paper suggested that cell damage caused by pulmonary vasoconstriction and alveolar cells caused directly by the drug are the two mechanisms that could possibly trigger hemorrhage.⁶⁰

In reviewing histopathological lung sections obtained during the necropsy of 52 cadavers with positive toxicological tests for cocaine (equal to or higher than 0.01 mg/dl) in blood, urine or bile, Bailey et al.⁶¹ found both acute and chronic alveolar hemorrhage (58 and 40% of the cases, respectively), pulmonary vascular congestion (88%), alveolar edema (77%) and foreign material and microgranulomas (11%).

Alveolitis, pneumonitis and interstitial fibrosis

Ongoing use of cocaine by inhalation can lead to pneumonitis⁶² and interstitial fibrosis.^41,52,53,62 In their histopathological study, Bailey et al.⁶¹ found pneumonitis characterized by thickening of the alveolar septum and infiltrate of neutrophils, lymphocytes, macrophages, and eosinophils, and interstitial fibrosis evidenced by type II pneumocyte hyperplasia.

Other authors⁶³ found extensive interstitial inflammatory infiltrate in the lungs of 14 out of 17 forensic necropsies performed on drug users. Their other findings were acute inflammatory alterations of alveolar walls with the presence of exsudate and cells in the alveoli, and vascular obstruction possibly caused by injection of mixtures for oral use (intravenous injection of adulterated cocaine). According to Oubeid et al.,⁴⁴ talcum powder is the agent most often used to adulterate the drug and this can cause pulmonary fibrosis.

Bronchiolitis obliterans with organizing pneumonia

Reports in the literature accept that the bronchiolitis obliterans with organizing pneumonia observed in some freebase cocaine users may be the result of a direct toxic effect of the drug on the airways.^41,49,64 It is also suggested that bronchiolitis obliterans with organizing pneumonia can occur as an idiopathic response to cocaine or substances used in its adulteration, or even from contaminants found in the paraphernalia used for smoking cocaine.⁶⁴

Vasculitis and pulmonary hypertension

Vasculitis associated with abusable drugs is well-documented in the literature, and some reports have described it as necrotizing vasculitis⁶⁵ that is similar to polyarteritis nodosa.⁶⁶ The mechanism by which cocaine causes vascular pathology remains unknown, but it has been associated with cerebral vasculitis.^67-70

Although there is mention in the literature that long-term use of intravenous cocaine is associated with pulmonary hypertension, very few cases have been reported and effectively proven.^42,71-74 Yakel and Eisenberg⁷¹ used transthoracic echocardiography to estimate the pulmonary artery pressure in 13 asymptomatic long-term users of intravenous cocaine, aged between 20 and 45 years, and obtained high pulmonary artery pressure (over 30 mmHg) in eight of these subjects. It is believed that such a pressure increase may be due to a reduction in the pulmonary vascular bed caused by the granulomatous process⁴⁴ that results from the addition of insoluble agents to the illicit drug (especially talcum powder, cellulose and starch). These agents generate a local chronic interstitial inflammatory process or microembolization in pulmonary arterioles and capillaries.

Clinical manifestations

The respiratory symptoms are varied and are either nonspecific or directly related to the pulmonary disease (Table 3). According to the literature, respiratory symptoms may appear a couple of hours after cocaine use, although in some cases they may occur within a few minutes. The most common clinical complaints related to lung involvement are chest pain^41-47 (pleuritic or non-pleuritic); dyspnea;^{46,47,53,57,64,77,78} cough^6,34 with expectoration of dark material (inhalation of residual combustion products) or blood material; hemoptysis^{42,53,57,64,77} (diffuse alveolar hemorrhage);^41,57 fever;^47,53,79 and asthma and recurring bronchospasm episodes (exacerbated or non-exacerbated).^41,49,54,55 Such symptoms have been reported mainly among crack users^6,80 and not with inhalation or intravenous use of cocaine. According to Suhl and Gorelick⁸¹ and Delbono et al.,⁸² the prevalence of such symptoms is highly variable: cough was reported in 26% and 61%, and dyspnea in 21% and 44%.

Pulmonary function tests

There are very few studies related to pulmonary function in cocaine users. A study performed in 1987 indicated that smoking cocaine could modify the forced expiratory flow.⁷⁷ Later studies, however, involving long-term cocaine users smoking freebase, showed spirometry with normal results in most of them,^40,81,83 with no evidence of obstructive or restrictive processes and association with nonspecific airway hyper-reactivity.⁸⁰

Only three of the several studies among crack users have shown decreased carbon monoxide diffusion capacity.^40,83,84 The authors of these studies even considered the possibility that this alteration could be related to the alveolar-capillary membrane or pulmonary vasculature lesion. Tashkin et al.,⁷⁷ on the other hand, did not observe any diffusion alteration among a cohort of 16 cocaine smokers (moderate users), who also used marijuana but did not use tobacco and/or intravenous drugs. According to Tashkin, in another paper published later, discrepancies in the diffusing capacity observed in other studies may be due to sample size; frequency, intensity or duration of cocaine smoking; effects from other drugs smoked; complications resulting from the use of intravenous drugs; or characteristics of the crack users themselves.⁸⁵

Recently, Goldbaum et al.⁸⁶ performed a study in Brazil on pulmonary function in 28 cocaine users, all male, with ages ranging from 18 to 50 years. Four of the subjects were also tobacco users and 24 mentioned marijuana and tobacco use. All subjects had respiratory symptoms (cough, expectoration of dark sputum, wheezing and dyspnea) during or after cocaine use, and had normal chest radiographs. One man presented micronodules and septal thickening compatible with respiratory bronchiolitis via high-resolution computed tomography scan. The spirometry values were normal, but mild alterations in carbon monoxide diffusing capacity (60-80% of predicted value) were detected in 7 subjects. The results obtained in that study are compatible with others in the literature.

Radiological findings

The radiological findings reported among cocaine users include atelectasis,⁴⁷ alveolar opacification (alveolar hemorrhage)^38,59 that can regress within a week,⁴¹ bilateral interstitial and alveolar infiltrates^51,52 (noncardiogenic pulmonary edema), transient⁵³ pulmonary infiltrates,⁷⁹ pneumonia, pulmonary nodules,⁶⁴ interstitial infiltrate and fibrosis. In crack users, however, the radiological abnormalities usually described are pneumothorax and pneumomediastinum.^48,78 Pneumopericardium,^48,87 hemopneumothorax⁴⁷ and bullous emphysema⁵⁰ (intravenous administration) have also been reported, especially in the upper lobes.

Chest computerized tomography (CT scan)

Yen et al.⁸⁸ described computed tomography scan and pathological findings from three patients who were tobacco smokers and frequent users of marijuana and especially cocaine (powder and/or crack). Their radiography was normal but high-resolution computed tomography scan showed a pattern suggesting septal thickening and diffuse micronodules. Pathological findings of transbronchial biopsy were compatible with desquamative pneumonia associated with respiratory bronchiolitis. On the basis of the clinical history and computed tomography and pathological findings, the authors suggest that the use of cocaine, marijuana and/or tobacco in association can cause pulmonary alterations that may progress with long-term illicit use.⁸⁸

Scintigraphy

To evaluate the alveolar-capillary membrane integrity among crack users, Susskind et al.⁸⁹ used lung clearance with ^99mTc-labeled DTPA (diethylenetriamine pentaacetic acid) in 23 subjects: seven used only crack, seven were tobacco and crack users, and nine used crack and marijuana simultaneously. The authors believe that the pulmonary epithelium lesion and consequent increase in lung permeability result from the direct action of crack vapors or pyrolysis products and the release of inflammatory mediators by effector or structural cells exposed to smoking.⁸⁹ However, Tashkin et al.⁹⁰ reported different results in another study. They believe that discrepancies found between the two studies are due to the previous smoking history and other exposure characteristics in the two populations of crack smokers studied.⁹⁰

Terra-Filho et al.⁹¹ studied Ga-67 lung scintigraphy in a group of 26 tobacco smokers, all with a history of illicit drug use (cocaine or cocaine and marijuana) and 22 reporting simultaneous use of marijuana and cocaine. The Ga-67 scintigraphy was positive in eight subjects, but lung parenchyma uptake in the control group subjects (tobacco smokers) was negative. Both groups had normal chest X-rays. The authors believe that the alterations in the Ga-67 scintigraphy studies detected in the illicit drug user group suggest lung inflammatory disease preceding the X-ray abnormalities.⁹¹

Bronchoalveolar lavage and sputum

In analyses of bronchoalveolar lavage among cocaine smokers, several authors have reported the presence of large numbers of eosinophils, Charcot-Leyden crystals,³⁸ and larger populations of alveolar macrophages, often containing hemosiderin, and increased protein concentrations^38,79 (higher than in congestive heart failure),⁵¹ which were greater than what was found in bronchoalveolar lavage among subjects that did not use this drug⁹² According to the same authors, these findings would represent not only higher alveolar epithelium permeability^38,51 but also probable interstitial alveolar inflammatory response to the aggression to the lungs from the drug^64,92

Other reports^36,93,94 mention that the alveolar macrophages recovered produced fewer inflammatory cytokines such as IL-6, IL-8 and tumor necrosis factor alpha, but produced larger amounts of the immunosuppressor factor TGF-beta (transforming growth factor beta) than from macrophages from non-cocaine smokers.³⁶ This indicates that chronic use of cocaine can limit lung response, thus making the user more susceptible to infections.

CONCLUSION

Whatever the form and administration route used, cocaine causes deleterious effects in the lungs. The respiratory symptoms are not specific, but carbonaceous sputum (dark material) is a characteristic of crack cocaine users. For the majority of long-term addicted subjects, pulmonary function tests show normal results with no evidence of obstructive or restrictive disturbances, but it is possible to identify pulmonary hypersensitivity reaction (bronchospasm) from such procedures when associated with clinical signs. Radiological findings are very important for establishing diagnosis of pulmonary complications in cocaine users (alveolar hemorrhage, pulmonary edema and fibrosis) and crack addicts (pneumothorax and/or pneumomediastinum). High-resolution computed tomography increases the sensitivity for detection of interstitial fibrosis, pneumonitis, alveolitis and bronchiolitis obliterans with organizing pneumonia, but the cost will restrict its use to individual cases with specific complaints. The principal noninvasive technique for investigating pulmonary hypertension is echocardiography. Scintigraphic evaluation of illicit drug users is expensive and is used only for academic purposes. Nowadays, bronchoalveolar lavage is used as a clinical tool for evaluating cocaine users only to rule out other diagnoses, and for research.

The diagnosis of illicit drug-induced lung disease may be difficult if an accurate history of drug use is not obtained. Establishing the diagnosis of drug-induced lung disease is important, because the appropriate treatment may also include referral to drug counseling or rehabilitation.

Sources of funding: Not declared

Conflict of interest: Not declared

Date of first submission: September 9, 2000

Last received: February 7, 2003

Accepted: July 15, 2003

PUBLISHING INFORMATION

Mário Terra Filho, MD. Associate Professor, Division of Pulmonary Diseases, Instituto do Coração – Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Chen Chin Yen – Deceased. Former Assistant Professor, Division of Pulmonary Diseases, Instituto do Coração – Hospital das Clínicas and Laboratório de Investigação Médica (LIM – 40) da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Ubiratan de Paula Santos, MD. Assistant Professor, Division of Pulmonary Diseases, Instituto do Coração – Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Daniel Romero Muñoz, MD. Associate Professor, Department of Legal Medicine, Laboratório de Investigação Médica (LIM – 40) da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Place where the manuscript was produced: Division of Respiratory Diseases, Instituto do Coração and Laboratório de Investigação Médica (LIM – 40) (Department of Legal Medicine), Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

• 1. Wetli CV. Illicit drug abuse. In: Craighead JE, editor. Pathology of Environmental and Occupational Disease. New York: Mosby; 1995.p.259-68.
• 2. O'Brien CP. Drug addiction or drug abuse. In: Hardman JG, Limbird LE, editors. Goodman & Gilman's. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 1996.p.557-77.
• 3. Bastos FIM, Lopes CS, Dias PRTP, Lima ES, Oliveira SB, Luz TP. Perfil de usuários de drogas I: Estudo de características de pacientes do NEPAD/UERJ - 1986/1987. [Profile of drug users: I. Study of characteristics of patients attended at NEPAD/UERJ - 1986/1987]. Rev ABP-APAL 1988; 10(2):47-52.
• 4. Rojas GE, Castro ME, Serna JJ, Garcia G. Análisis regional sobre el uso de drogas en la población estudantil del Mexico. [Regional analysis of drug use in the Mexican student population]. Salud Publica Mex 1987;29(4):331-44.
• 5. Nappo SA, Galduróz JCF, Noto AR. Uso do "crack" em São Paulo: fenômeno emergente? [Crack use in São Paulo city: an emergent phenomenon?]. Rev ABP-APAL 1994;16(2):75-83.
• 6. Smart RG. Crack cocaine use: a review of prevalence and adverse effects. Am J Drug Alcohol Abuse 1991;17(1):13-26.
• 7. Escobedo LG, Ruttenber AJ, Agocs MM, Anda RF, Wetli CV. Emerging patterns of cocaine use and the epidemic of cocaine overdose deaths in Dade County, Florida. Arch Pathol Lab Med 1991;115(9):900-5.
• 8. Galduróz JCF, D'Almeida V, Carvalho V, Carlini EA. III Levantamento sobre o uso de drogas entre estudantes de 1ş e 2ş graus em 10 capitais brasileiras 1993. CEBRID - Escola Paulista de Medicina 1993.p.1-81.
• 9. Galduróz JCF, Noto AR, Carlini EA. IV Levantamento sobre o uso de drogas entre estudantes de 1ş e 2ş graus em 10 capitais brasileiras 1997. CEBRID - Escola Paulista de Medicina 1997.p.1-130.
• 10. Andrade AG, Queiroz S, Vilaboim RCM, et al. Uso de álcool e drogas entre alunos de graduação da Universidade de São Paulo (1996). Rev ABP-APAL 1997;19(2):53-9.
• 11. Departamento Estadual de Narcóticos (DENARC). São Paulo. Relatório anual 1997.p.1-67.
• 12. Bucher RE, Totugui ML. Conocimiento y uso de drogas entre alumnos de Brasília. [Drugs: knowledge and use among students in Brasília]. Acta Psiquiatr Psicol Am Lat 1988;34(2):113-26.
• 13. Castel S, Malbergier A. Farmacodependências: estudo comparativo de uma população atendida em serviço especializado: 1984-1988. [Psychoactive substance dependence: comparative analysis of a population attended at a specialist service: 1984-1988]. Rev ABP-APAL 1989;11(3):126-32.
• 14. Cardim MS, Morgado AF, Azevedo BA. Drogas: aspectos familiares e diagnóstico. [Drugs: familial and diagnostic aspects]. Rev ABP-APAL 1988;11(2):62-8.
• 15. Gaensler EA, Wright GW. Evaluation of respiratory impairment. Arch Environ Health 1966;12(2):146-89.
• 16. Dean RA, Harper ET, Dumaual N, Stoeckel DA, Bosron WF. Effects of ethanol on cocaine metabolism: formation of cocaethylene and norcocaethylene. Toxicol Appl Pharmacol 1992;117(1):1-8.
• 17. Farré M, de la Torre R, Llorente M, Lamas X, Ugena B, Segura J, Camí J. Alcohol and cocaine interactions in humans. J Pharmacol Exp Ther 1993;266(3):1364-73.
• 18. Tardiff K, Marzuk PM, Leon AC, et al. Cocaine, opiates, and ethanol in homicides in New York City: 1990 and 1991. J Forensic Sci 1995;40(3):387-90.
• 19. Grant BF, Harford TC. Concurrent and simultaneous use of alcohol with cocaine: results of national survey. Drug Alcohol Depend 1990;25(1):97-104.
• 20. Perez-Reyes M, Jeffcoat AR. Ethanol/cocaine interaction cocaine and cocaethylene plasma concentrations and their relationship to subjective and cardiovascular effects. Life Sci 1992;51(8):553-63.
• 21. Bunn WH, Giannini AJ. Cardiovascular complications of cocaine abuse. Am Fam Physician 1992;46(3):769-73.
• 22. Tardiff K, Gross E, Wu J, Stajic M, Millman R. Analysis of cocaine-positive fatalities. J Forensic Sci 1989;34(1):53-63.
• 23. Muñoz DR, Souza MB, Yen CC, Leyton V, Silva OA. Verificação da presença de álcool, canabinoides e cocaína em vítimas de morte violenta. XV Congresso Brasileiro de Medicina Legal; 1998, Sep 9-13; Salvador, Brazil. p.15.
• 24. Toledo FCP, Silva AO, Leyton V, editors. Detection of benzoylecgonine in hair of cocaine users using fluorescence polarization immunoassay. In: 2nd European Meeting on Hair Analysis. Program and Abstracts. Society of Hair Testing; 1999, Jun 14-16; Martigny, Switzerland. p.4
• 25. Maldonado AL, De Albornoz EOC. Drogas de abuso. In: Masson AS, editor. Medicina legal y toxicología. 5.ª ed. Barcelona: MASSON ed.; 1998. p.892-907.
• 26. Regan TJ. Alcohol and the cardiovascular system. JAMA 1990;264(3):377-81.
• 27. Benowitz NL. Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol 1993;72(1):3-12.
• 28. Madden JA, Powers RH. Effect of cocaine and cocaine metabolites on cerebral arteries in vitro. Life Sci 1990; 47(13):1109-14.
• 29. Seale TW. Genetic differences in response to cocaine and stimulant drugs. In: Crabbe JC Jr, Harris RA, editors. The genetics basis of alcohol and drug actions. New York: Plenum Press; 1991.p.295-321.
• 30. Warner EA, Kosten TR, O'Connor PG. Pharmacotherapy for opioid and cocaine abuse. Med Clin North Am 1997; 81(4):909-25.
• 31. Foltin RW, Fischman MW. Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 1991;257(1):247-61.
• 32. Chasin AAM, Mídio AF. Aspecto toxicológico da overdose de cocaína. [Toxicology of cocaine overdose]. Rev Farm Bioquim Univ São Paulo 1991;27(1):1-27.
• 33. Laposata EA, Mayo GL. A review of pulmonary pathology and mechanisms associated with inhalation of freebase cocaine (crack). Am J Forensic Med Pathol 1993;14(1):1-9.
• 34. Petersen RC. A history of cocaine. In: Petersen RC, Stilman RC, editors. Cocaine. Monograph 13. Washington DC: National Institute of Drug Abuse; 1977.p.1-16.
• 35. Jentzen J. Medical complications of cocaine abuse. Am J Clin Pathol 1993;100(5):475-6.
• 36. Thadani PV. NIDA conference report on cardiopulmonary complications of "crack" cocaine use. Clinical manifestations and pathophysiology. Chest 1996;110(4):1072-6.
• 37. Khalsa ME, Tashkin DP, Perrochet B. Smoked cocaine: patterns of use and pulmonary consequences. J Psychoactive Drugs 1992;24(3):265-72.
• 38. Heffner JE, Harley RA, Schabel SI. Reações pulmonares devidas ao abuso de drogas ilícitas. In: Cooper JAB, editor. Clínicas de doenças pulmonares. Rio de Janeiro: Interlivros; 1990. p.151-9.
• 39. Jeffcoat AR, Perez-Reyes M, Hill JM, Sadler BM, Cook CE. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos 1989;17(2):153-9.
• 40. Tashkin DP, Khalsa ME, Gorelick D, et al. Pulmonary status of habitual cocaine smokers. Am Rev Respir Dis 1992; 145(1):92-100.
• 41. Haim DY, Lippmann ML, Goldberg SK, Walkenstein MD. The pulmonary complications of crack cocaine. A comprehensive review. Chest 1995;107(1):233-40.
• 42. Calabuig JAG. Los grandes síndromes toxicológicos. In: Masson AS, editor. Medicina legal y toxicología, 5ª ed. Barcelona: Masson; 1998. p.629-48.
• 43. Cooper CB, Bai TR, Heyderman E, et al. Cellulose granuloma in the lungs of a cocaine sniffer. Br Med J (Clin Res Ed) 1983;286(6383):2021-2.
• 44. Oubeid M, Bickel JT, Ingram EA, Scott GC. Pulmonary talc granulomatosis in a cocaine sniffer. Chest 1990;98(1):237-9.
• 45. Shesser R, Davis C, Edelstein S. Pneumomediastinum and pneumothorax after inhaling alkaloidal cocaine. Ann Emerg Med 1981;10(4):213-5.
• 46. Aroesty DJ, Stanley RB, Crockett DM. Pneumomediastinum and cervical emphysema from the inhalation of "free based" cocaine: Report of three cases. Otolaryngol Head Neck Surg 1986;94(3):372-4.
• 47. Eurman DW, Potash HI, Eyler WR, Paganussi PJ, Beute GH. Chest pain and dyspnea related to "crack" cocaine smoking: value of chest radiography. Radiology 1989;172(2):459-62.
• 48. Leitman BS, Greengart A, Wasser HJ. Pneumomediastinum and pneumopericardium after cocaine abuse. Am J Roentgenol 1988;151(3):614.
• 49. Ettinger NA, Albin RJ. A review of the respiratory effects of smoking cocaine. Am J Med 1989;87(6):664-8.
• 50. Gurney JW, Bates FT. Pulmonary cystic disease: comparison of Pneumocystis carinii pneumatoceles and bullous emphysema due to intravenous drug abuse. Radiology 1989;173(1):27-31.
• 51. Cucco RA, Yoo OH, Cregler L, Chang JC. Nonfatal pulmonary edema after "freebase" cocaine smoking. Am Rev Respir Dis 1987;136(1):179-81.
• 52. Hoffman CK, Goodman PC. Pulmonary edema in cocaine smokers. Radiology 1989;172(2):463-65.
• 53. Kissner DG, Lawrence WD, Selis JE, Flint A. Crack lung: pulmonary disease caused by cocaine abuse. Am Rev Respir Dis 1987;136(5):1250-2.
• 54. Rebhun J. Association of asthma and freebase smoking. Ann Allergy 1988;60(4):339-42.
• 55. Rubin RB, Neugarten J. Cocaine associated asthma. Am J Med 1990;88(4):438-9.
• 56. Godwin JE, Harley RA, Miller KS, Heffner JE, et al. Cocaine, pulmonary hemorrhage, and hemoptysis. Ann Intern Med 1989;110(10):843.
• 57. Murray RJ, Smialek JE, Golle M, Albin RJ. Pulmonary artery medial hypertrophy in cocaine users without foreign particle microembolization. Chest 1989;96(5):1050-3.
• 58. Walek JW, Masson RG, Siddiqui M. Pulmonary hemorrhage in a cocaine abuser. Chest 1989;96(1):222.
• 59. Murray RJ, Albin RJ, Mergner W, Criner GJ. Diffuse alveolar hemorrhage temporally related to cocaine smoking. Chest 1988;93(2):427-9.
• 60. Bouchi J, el Asmar B, Couetil JP, Gédéon E, Bouchi N. Hémorragie alvéolaire après inhalation de cocaïne. [Alveolar hemorrhage after cocaine inhalation]. Presse Med 1992; 21(22):1025-6.
• 61. Bailey ME, Fraire AE, Greenberg SD, Barnard J, Cagle PT. Pulmonary histopathology in cocaine abusers. Hum Pathol 1994;25(2):203-7.
• 62. O'Donnell AE, Mappin FG, Sebo TJ, Tazelaar H. Interstitial pneumonitis associated with "crack" cocaine abuse. Chest 1991;100(4):1155-7.
• 63. Byers JM, Soin JS, Fisher RS, Hutchins GM. Acute pulmonary alveolitis in narcotics abuse. Arch Pathol 1975;99(5):273-7.
• 64. Patel RC, Dutta D, Schonfeld SA. Free-base cocaine use associated with bronchiolitis obliterans organizing pneumonia. Ann Intern Med 1987;107(2):186-7.
• 65. Citron BP, Halpern M, McCarron M, Lundberg GD, McCormick R, Pincus IJ, Tatter D, Haverback BJ. Necrotizing angiitis associated with drug abuse. N Engl J Med 1970; 283(19):1003-11.
• 66. Angiitis in drug abusers. N Engl J Med 1971;284(2):111-3.
• 67. Merkel PA, Koroshetz WJ, Irizarry MC, Cudkowicz ME. Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum 1995;25(3):172-83.
• 68. Brust JC. Vasculitis owing to substance abuse. Neurol Clin 1997;15(4):945-57.
• 69. Orriols R, Muñoz X, Ferrer J, Huget P, Morell F. Cocaine-induced Churg-Strauss vasculitis. Eur Respir J 1996;9(1):175-7.
• 70. Armstrong M, Shikani AH. Nasal septal necrosis mimicking Wegener's granulomatosis in a cocaine abuser. Ear Nose Throat J 1996;75(9):623-6.
• 71. Yakel DL, Eisenberg MJ. Pulmonary artery hypertension in chronic intravenous cocaine users. Am Heart J 1995;130(2):398-9.
• 72. Tomashefski JF, Hirsch CS. The pulmonary vascular lesions of intravenous drug abuse. Hum Pathol 1980;11(2):133-45.
• 73. Talebzadeh VC, Chevrolet JC, Chatelain P, Helfer C, Cox JN. Myocardite à éosinophiles et hypertension pulmonaire chez une toxicomane. Etude anatomo-clinique et brève revue de la littérature. [Eosinophilic myocarditis and pulmonary hypertension in a drug addict. Anatomoclinical study and brief review of the literature]. Ann Pathol 1990;10(1):40-6.
• 74. Kleerup EC, Wong M, Marques-Magallanes JA, Goldman MD, Tashkin DP. Acute effects of intravenous cocaine on pulmonary artery pressure and cardiac index in habitual crack smokers. Chest 1997;111(1):30-5.
• 75. Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest 1997; 112(2):319-26.
• 76. Forrester JM, Steele AW, Waldron JA, Parsons PE. Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathological findings. Am Rev Respir Dis 1990; 142(2):462-7.
• 77. Tashkin DP, Simmons MS, Coulson AH, Clark VA, Gong H. Respiratory effects of cocaine "freebasing" among habitual users of marijuana with or without tobacco. Chest 1987;92(4):638-44.
• 78. Goldberg RE, Lipuma JP, Cohen AM. Pneumomediastinum associated with cocaine abuse: a case report and review of the literature. J Thorac Imaging 1987;2(3):88-9.
• 79. Klinger JR, Bensadoun E, Corrao WM. Pulmonary complications from alveolar accumulation of carbonaceous material in a cocaine smoker. Chest 1992;101(4):1171-3.
• 80. Tashkin DP, Kleerup EC, Koyal SN, Marques JA, Goldman MD. Acute effects of inhaled and i.v. cocaine on airways dynamics. Chest 1996;110(4):904-10.
• 81. Suhl J, Gorelick DA. Pulmonary function in male cocaine smokers. Am Rev Respir Dis 1998;137:A448.
• 82. Del Bono EA, O'Brien K, Murphy RLH Jr. Lung sound abnormalities in cocaine freebasers. Substance abuse 1989;10:A201.
• 83. Itkonen J, Schnoll S, Glassroth J. Pulmonary dysfunction in "freebase" cocaine users. Arch Intern Med 1984;144(11):2195-7.
• 84. Weiss RD, Goldenheim PD, Mirin SM, Hales CA, Mendelson JH. Pulmonary dysfunction in cocaine smokers. Am J Psychiatry 1981;138(8):1110-2.
• 85. Tashkin DP. What is the true impact of crack on the lung? Chest 1995;108(4):1180-1.
• 86. Goldbaum TS, Yen CC, Santos UP, Noritomi DT, Terra Filho M. Alterações pulmonares em usuários crônicos de cocaína Estudo preliminar. J Pneumol 1998;24(1):S99.
• 87. Adrouny A, Magnusson P. Pneumopericardium from cocaine inhalation. N Engl J Med 1985;313(1):48-9.
• 88. Yen CC, Santos UP, Leite M, Capellozi VL, Terra Filho M. Alterações tomográficas e anátomo-patológicas em usuários de cocaína. J Pneumol 1998;24(1):S114.
• 89. Susskind H, Weber DA, Volkow ND, Hitzemann R. Increased lung permeability following long-term use of free-base cocaine (crack). Chest 1991;100(4):903-9.
• 90. Tashkin DP, Kleerup EC, Hoh CK, Kim KJ, Webber MM, Gil E. Effects of "crack" cocaine on pulmonary alveolar permeability. Chest 1997;112(2):327-35.
• 91. Terra-Filho M, Yen CC, Leite MC, Andrade AG, Santos UP, Goldbaum TS, Soares Junior J, Meneghetti JC. Inflammatory disease assessed by Gallium-67 lung scan in illicit drugs (cocaine/marijuana) users (IDU) in São Paulo, Brazil. Amer J Respir Crit Care Med 1999;159(3):A621.
• 92. Tashkin DP. Pulmonary complications of smoked substance abuse. West J Med 1990;152(5):525-30.
• 93. Mao JT, Zhu LX, Sharma S, et al. Cocaine inhibits human endothelial cell IL-8 production: the role of transforming growth factor-beta. Cell Immunol 1997;181(1):38-43.
• 94. Baldwin GC, Buckley DM, Roth MD, Kleerup EC, Tashkin DP. Acute activation of circulating polymorphonuclear neutrophils following in vivo administration of cocaine. A potential etiology for pulmonary injury. Chest 1997; 111(3):698-705.

Publication Dates

• Publication in this collection
  01 July 2004
• Date of issue
  Feb 2004

History

• Reviewed
  07 Feb 2003
• Received
  09 Sept 2000
• Accepted
  15 July 2003